In addition, the alteration of pAKT (Ser473) demonstrated that FTO is implicated in AKT phosphorylation to regulate ccRCC progression (Fig. 2F and Supplementary Fig. 4B, C). Here, FTO is linked to nonpapillary renal cell carcinoma.